We have completed the development of our Clinical Data Management SOPs and supporting processes, which will take effect in mid-October 2026.
The new framework covers the full data management lifecycle and provides a consistent approach to the start-up, conduct and close-out of clinical trials.
With these processes in place, we can now take on Data Management activities in-house and support our clients directly throughout the clinical trial lifecycle.
This marks an important step in expanding Staburo’s Data Management capabilities and provides a solid foundation for the delivery of high-quality, inspection-ready clinical trial data.
